Vitrolife AB (ST:VITR) — Stock Price

Skr89.00 SEK
▼ -1.11% today

Vitrolife AB (ST:VITR) is currently trading at Skr89.00 SEK, down 1.11% today. Over the past 52 weeks, shares have ranged between Skr85.20 and Skr151.10. This page tracks Vitrolife AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see VITR market cap overview.

Vitrolife AB (VITR) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Vitrolife AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Vitrolife AB Income Statement — Revenue, Profit & Earnings by Year

Vitrolife AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr3.44 Billion Skr3.61 Billion Skr3.51 Billion Skr3.23 Billion Skr1.68 Billion
Cost of Revenue Skr1.69 Billion Skr1.47 Billion Skr1.53 Billion Skr1.45 Billion Skr634.71 Million
Gross Profit Skr1.75 Billion Skr2.14 Billion Skr1.98 Billion Skr1.78 Billion Skr1.05 Billion
Research & Development Skr111.00 Million Skr117.00 Million Skr228.00 Million Skr143.00 Million Skr114.45 Million
SG&A Skr512.00 Million Skr478.00 Million Skr433.00 Million Skr400.00 Million Skr259.46 Million
Total Operating Expenses Skr1.13 Billion Skr1.36 Billion Skr5.57 Billion Skr1.15 Billion Skr619.68 Million
Operating Income Skr616.00 Million Skr783.00 Million Skr-3.59 Billion Skr654.00 Million Skr435.38 Million
EBITDA Skr-4.41 Billion Skr783.00 Million Skr-3.19 Billion Skr977.00 Million Skr579.60 Million
EBIT Skr-4.83 Billion Skr341.00 Million Skr-3.61 Billion Skr581.00 Million Skr470.69 Million
Interest Expense Skr87.00 Million Skr109.00 Million Skr102.00 Million Skr60.00 Million Skr10.00 Million
Income Before Tax Skr-4.89 Billion Skr674.00 Million Skr-3.71 Billion Skr537.00 Million Skr459.97 Million
Income Tax Expense Skr127.00 Million Skr160.00 Million Skr139.00 Million Skr143.00 Million Skr116.41 Million
Net Income Skr-5.01 Billion Skr513.00 Million Skr-3.85 Billion Skr394.00 Million Skr341.00 Million

Vitrolife AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Vitrolife AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr11.12 Billion Skr17.45 Billion Skr16.33 Billion Skr20.55 Billion Skr19.43 Billion
Total Current Assets Skr2.09 Billion Skr2.36 Billion Skr1.91 Billion Skr1.57 Billion Skr1.41 Billion
Cash & Equivalents Skr809.00 Million Skr1.14 Billion Skr861.00 Million Skr578.00 Million Skr630.09 Million
Short-term Investments — — — — —
Net Receivables Skr796.00 Million Skr767.00 Million Skr503.00 Million Skr542.00 Million Skr431.16 Million
Inventory Skr413.00 Million Skr422.00 Million Skr413.00 Million Skr405.00 Million Skr312.89 Million
Property, Plant & Equipment Skr515.00 Million Skr428.00 Million Skr349.00 Million Skr318.00 Million Skr332.97 Million
Goodwill Skr4.44 Billion Skr10.12 Billion Skr9.59 Billion Skr13.87 Billion Skr12.99 Billion
Total Liabilities Skr3.23 Billion Skr3.81 Billion Skr3.61 Billion Skr3.81 Billion Skr4.09 Billion
Total Current Liabilities Skr615.00 Million Skr705.00 Million Skr557.00 Million Skr621.00 Million Skr954.33 Million
Long-term Debt Skr1.49 Billion Skr1.84 Billion Skr1.88 Billion Skr1.99 Billion Skr1.94 Billion
Net Debt Skr796.00 Million Skr954.00 Million Skr1.23 Billion Skr1.65 Billion Skr1.85 Billion
Total Stockholder Equity Skr7.89 Billion Skr13.64 Billion Skr12.72 Billion Skr16.74 Billion Skr15.32 Billion
Retained Earnings Skr-6.75 Billion Skr-1.61 Billion Skr-1.99 Billion Skr2.00 Billion Skr1.73 Billion

Vitrolife AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Vitrolife AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr635.00 Million Skr907.00 Million Skr757.00 Million Skr636.00 Million Skr384.31 Million
Capital Expenditures Skr270.00 Million Skr92.00 Million Skr119.00 Million Skr87.00 Million Skr62.45 Million
Free Cash Flow Skr365.00 Million Skr907.00 Million Skr638.00 Million Skr549.00 Million Skr321.86 Million
Investing Cash Flow Skr-302.00 Million Skr-377.00 Million Skr-124.00 Million Skr-144.00 Million Skr-6.52 Billion
Financing Cash Flow Skr-553.00 Million Skr-286.00 Million Skr-300.00 Million Skr-582.00 Million Skr5.75 Billion
Dividends Paid Skr-149.00 Million Skr-135.00 Million Skr-115.00 Million Skr110.00 Million Skr88.31 Million
Stock-Based Compensation Skr15.00 Million Skr14.00 Million Skr17.00 Million Skr10.00 Million Skr4.76 Million
Depreciation Skr427.00 Million Skr442.00 Million Skr425.00 Million Skr396.00 Million Skr108.91 Million
Change in Cash Skr-326.00 Million Skr274.00 Million Skr283.00 Million Skr-52.00 Million Skr-343.47 Million

Vitrolife AB Earnings History — EPS Actual vs. Analyst Estimates

Track Vitrolife AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 16, 2026 — 0.82 —
Apr 23, 2026 0.74 0.75 -1.33%
Feb 03, 2026 0.66 -39.00 +101.69%
Oct 23, 2025 0.75 1.06 -28.94%
Jul 17, 2025 0.74 1.00 -26.00%
Apr 24, 2025 0.74 0.85 -12.94%
Jan 30, 2025 1.02 1.06 -3.77%
Oct 24, 2024 0.85 1.05 -19.05%